<table border="1" id="inv-33423751-4066-4b21-bfc5-43aa905181e2" width="390" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="inv-2c7b99e4-4de1-4145-9081-159f5d761c11">Table 16. Mean Pharmacokinetic Parameters in Pediatric Patients With Epilepsy</caption>
<col width="32.6%"></col>
<col width="17.9%"></col>
<col width="13.8%"></col>
<col width="12.3%"></col>
<col width="23.3%"></col>
<tbody>
<tr id="id_8a5b7064-0397-4d22-95a2-06f4ffe44c8e">
<td align="center" stylecode="Botrule Toprule Rrule Lrule" valign="middle"> Pediatric Study Population </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> Number of Subjects </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> T<sub>max</sub> (hr) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> t<sub>½</sub> (hr) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> Cl/F (mL/min/kg) </td>
</tr>
<tr id="id_eab18829-7f08-43cb-80b8-5dc0d40f27a3">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">
<content stylecode="bold">Ages 10 months to 5.3 years</content>
</td>
<td align="left" stylecode="Botrule Rrule" valign="middle">   </td>
<td align="left" stylecode="Botrule Rrule" valign="middle">   </td>
<td align="left" stylecode="Botrule Rrule" valign="middle">   </td>
<td align="left" stylecode="Botrule Rrule" valign="middle">   </td>
</tr>
<tr id="id_c3fd7f47-c3d8-4ae2-af81-acaa70b7b0d1">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Patients taking carbamazepine, phenytoin, phenobarbital, or primidone<footnote id="id-91930a4b-0304-4da2-805b-e7aac775c954">Carbamazpine, phenobarbital, phenytoin, and primidone have been shown to increase the apparent clearance of lamotrigine. Estrogen-containing oral contraceptives and rifampin have also been shown to increase the apparent clearance of lamotrigine [<content stylecode="italics">see Drug Interactions (<linkhtml href="#i4i_interactions_id_364be10c-c386-441a-b287-c321179e377d">7</linkhtml>)</content>].</footnote>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 10 </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 3.0 (1.0 to 5.9) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 7.7 (5.7 to 11.4) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 3.62 (2.44 to 5.28) </td>
</tr>
<tr id="id_d2e7816e-0e3b-4902-a585-1bfec4f32a1c">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Patients taking AEDs with no known effect on the apparent clearance of lamotrigine </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 7 </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 5.2 (2.9 to 6.1) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 19.0 (12.9 to 27.1) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 1.2 (0.75 to 2.42) </td>
</tr>
<tr id="id_73ec8b2f-8d51-4992-9de0-d2eafb311fc2">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Patients taking valproate only </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 8 </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 2.9 (1.0 to 6.0) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 44.9 (29.5 to 52.5) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 0.47 (0.23 to 0.77) </td>
</tr>
<tr id="id_65e829cc-c4b5-4f18-8dda-79b084608c5e">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">
<content stylecode="bold">Ages 5 to 11 years</content>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">   </td>
<td align="center" stylecode="Botrule Rrule" valign="middle">   </td>
<td align="center" stylecode="Botrule Rrule" valign="middle">   </td>
<td align="center" stylecode="Botrule Rrule" valign="middle">   </td>
</tr>
<tr id="id_58041318-f333-4a5e-9be8-d1fdaa1a5ee6">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Patients taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="id-91930a4b-0304-4da2-805b-e7aac775c954"></footnoteref>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 7 </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 1.6 (1.0 to 3.0) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 7.0 (3.8 to 9.8) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 2.54 (1.35 to 5.58) </td>
</tr>
<tr id="id_114e2cfd-9eb0-4410-ba6e-067e1ae51cf3">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Patients taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="id-91930a4b-0304-4da2-805b-e7aac775c954"></footnoteref> plus valproate </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 8 </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 3.3 (1.0 to 6.4) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 19.1 (7.0 to 31.2) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 0.89 (0.39 to 1.93) </td>
</tr>
<tr id="id_3425a3a8-2aac-4c50-904f-1db1a890ac46">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Patients taking valproate only<footnote id="id-3f192239-8706-469d-90e0-0b605cd81e60">Two subjects were included in the calculation for mean T<sub>max</sub>.</footnote>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 3 </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 4.5 (3.0 to 6.0) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 65.8 (50.7 to 73.7) </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 0.24 (0.21 to 0.26) </td>
</tr>
<tr id="id_57367b64-e88e-4aa1-a062-a773f305c8d9">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">
<content stylecode="bold">Ages 13 to 18 years</content>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">   </td>
<td align="center" stylecode="Botrule Rrule" valign="middle">   </td>
<td align="center" stylecode="Botrule Rrule" valign="middle">   </td>
<td align="center" stylecode="Botrule Rrule" valign="middle">   </td>
</tr>
<tr id="id_0ae13ac3-b0f8-4544-9768-cf1dc9dcd15b">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Patients taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="id-91930a4b-0304-4da2-805b-e7aac775c954"></footnoteref>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 11 </td>
<td align="center" stylecode="Botrule Rrule" valign="middle">
<footnote id="id-65f4f0c7-9803-4147-8513-0f6922fbc6c2">Parameter not estimated.</footnote>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">
<footnoteref idref="id-65f4f0c7-9803-4147-8513-0f6922fbc6c2"></footnoteref>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 1.3 </td>
</tr>
<tr id="id_70fa5811-9f68-4c63-836e-4d7369729d72">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Patients taking carbamazpine, phenytoin, phenobarbital, or primidone<footnoteref idref="id-91930a4b-0304-4da2-805b-e7aac775c954"></footnoteref> plus valproate </td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 8 </td>
<td align="center" stylecode="Botrule Rrule" valign="middle">
<footnoteref idref="id-65f4f0c7-9803-4147-8513-0f6922fbc6c2"></footnoteref>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">
<footnoteref idref="id-65f4f0c7-9803-4147-8513-0f6922fbc6c2"></footnoteref>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 0.5 </td>
</tr>
<tr id="id_12134458-5846-4dbf-97b7-852cf5fc3e9c">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Patients taking valproate only </td>
<td align="center" stylecode="Rrule" valign="middle"> 4 </td>
<td align="center" stylecode="Rrule" valign="middle">
<footnoteref idref="id-65f4f0c7-9803-4147-8513-0f6922fbc6c2"></footnoteref>
</td>
<td align="center" stylecode="Rrule" valign="middle">
<footnoteref idref="id-65f4f0c7-9803-4147-8513-0f6922fbc6c2"></footnoteref>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle"> 0.3 </td>
</tr>
</tbody>
</table>